This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Hammersmith Imanet Limited. Active years: 2013.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2013
Title: Bo Shan - Innovator in In Vivo Imaging Agents
Introduction
Bo Shan is a notable inventor based in London, GB. He has made significant contributions to the field of pharmaceutical sciences, particularly in the development of imaging agents. His work focuses on creating novel compounds that can be utilized for both imaging and therapeutic purposes.
Latest Patents
Bo Shan holds a patent for "Tetracyclic indole derivatives as in vivo imaging agents and having peripheral benzodiazepine receptor affinity (PBR)." This invention provides novel tetracyclic indole compounds that serve as in vivo imaging agents or therapeutic agents. The patent also outlines a method for preparing these imaging agent compounds, along with a precursor for use in the preparation process. Additionally, the invention includes pharmaceutical compositions that comprise these compounds, which are suitable for in vivo imaging. A kit for preparing the pharmaceutical composition is also provided, along with the use of the compound for imaging or treating conditions associated with PBR.
Career Highlights
Bo Shan is currently associated with Hammersmith Imanet Limited, where he continues to innovate in the field of imaging agents. His work has garnered attention for its potential applications in medical imaging and treatment.
Collaborations
Throughout his career, Bo Shan has collaborated with esteemed colleagues such as Erik Arstad and Ian Wilson. These collaborations have further enhanced the impact of his research and innovations.
Conclusion
Bo Shan's contributions to the field of in vivo imaging agents exemplify the importance of innovation in pharmaceutical sciences. His patented work not only advances medical imaging techniques but also holds promise for therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile